Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 442,497
  • Shares Outstanding, K 26,818
  • Annual Sales, $ 39,010 K
  • Annual Income, $ -3,820 K
  • EBIT $ -3 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.17
  • Price/Sales 10.57
  • Price/Cash Flow N/A
  • Price/Book 17.82

Options Overview Details

View History
  • Implied Volatility 118.53% (+12.39%)
  • Historical Volatility 52.50%
  • IV Percentile 90%
  • IV Rank 69.06%
  • IV High 152.46% on 12/02/25
  • IV Low 42.81% on 08/12/25
  • Expected Move (DTE 14) 2.41 (14.36%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 18
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 1,755
  • Open Int (30-Day) 2,024
  • Expected Range 14.40 to 19.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.29
  • Low Estimate 0.09
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +1,050.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.28 +10.01%
on 12/01/25
20.03 -16.09%
on 11/06/25
-1.64 (-8.89%)
since 11/04/25
3-Month
15.28 +10.01%
on 12/01/25
23.00 -26.91%
on 09/30/25
-1.06 (-5.93%)
since 09/04/25
52-Week
11.09 +51.62%
on 04/07/25
23.00 -26.91%
on 09/30/25
+4.62 (+37.90%)
since 12/04/24

Most Recent Stories

More News
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

Q3 2025 product sales of $22.5 million, representing 129% growth over Q3 2024 and 19 th straight quarter of sequential product sales growth Q3 2025 basic and fully diluted GAAP EPS of $(0.07), non-GAAP...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

Q2 2025 product sales of $18.9 million, representing 108% growth over Q2 2024 and the 18 th straight quarter of sequential product sales growth Q2 2025 basic and fully diluted GAAP EPS of $(0.10), non-GAAP...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

DEER PARK, Ill., July 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

ETON : 16.81 (+1.88%)
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

ETON : 16.81 (+1.88%)

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

3rd Resistance Point 17.95
2nd Resistance Point 17.48
1st Resistance Point 17.14
Last Price 16.81
1st Support Level 16.33
2nd Support Level 15.86
3rd Support Level 15.52

See More

52-Week High 23.00
Fibonacci 61.8% 18.45
Fibonacci 50% 17.04
Last Price 16.81
Fibonacci 38.2% 15.64
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar